30 Eylül 2012 Pazar

Dr. Amir Hamrahian Answers Our Questions About Cushing's and Korlym

To contact us Click HERE

October 1, 2012 at 6:30 PM eastern, Dr. Amir Hamrahian will answer our questions about Cushing's, pituitary or adrenal issues and Korlym (mifepristone) in BlogTalkRadio at http://www.blogtalkradio.com/cushingshelp/2012/10/01/dr-amir-hamrahian-answers-our-questions

 

You may listen live at the link above.  The episode will be added to the Cushing's Help podcast after the show is over.  Listen to the podcasts by searching for Cushings in the iTunes podcast area or click here: http://itunes.apple.com/podcast/cushingshelp-cushie-chats/id350591438

 

Dr. Hamrahian has had patients on Korlym for about 4 years.

 

Please submit your questions below or email them to CushingsHelp@gmail.com before Sunday, September 30.

 

From Dr. Hamrahian's bio at http://my.clevelandclinic.org/staff_directory/staff_display.aspx?doctorid=3676

 

 

Amir Hamrahian, M.D. 

(216) 444-6568

Amir Hamrahian, M.D.

Appointed: 2000

Request an Appointment
Department:Endocrinology, Diabetes and Metabolism
Location:Cleveland Clinic Main Campus
Mail Code F20 
9500 Euclid Avenue
ClevelandOH 44195
Appointment:(216) 444-6568
Desk:(216) 445-8538
Fax:(216) 445-1656
Department:Brain Tumor and Neuro-Oncology Center
Location:Cleveland Clinic Main Campus
Mail Code R20 
9500 Euclid Avenue
ClevelandOH 44195
Appointment:(216) 444-6568
Desk:(216) 445-8538
Fax:(216) 445-1656
Surgeon:
No
Treats:
Adults Only

Research & Publications †

( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Biographical Sketch

Amir H. Hamrahian, MD, is a Staff member in the Department of Endocrinology, Diabetes and Metabolism at Cleveland Clinic's main campus, having accepted that appointment in 2005. Prior to that appointment, he was also a clinical associate there for nearly five years. 

His clinical interests include pituitary and adrenal disorders.

Dr. Hamrahian received his medical degree from Hacettepe University in Ankara, Turkey, and upon graduation was a general practitioner in the provinces of Hamadan and Tehran, Iran. He completed an internal medicine residency at the University of North Dakota, Fargo, and an endocrinology fellowship at Case Western Reserve University and University Hospitals, Cleveland.

In 2003, he received the Teacher of the Year award from Cleveland Clinic's Department of Endocrinology, Diabetes and Metabolism. Dr. Hamrahian speaks three languages -- English, Turkish and Farsi -- and is board-certified in internal medicine as well as endocrinology, diabetes and metabolism. He is a member of the Endocrine Society, Pituitary Society and the American Association of Clinical Endocrinologists.

Education & Fellowships

Fellowship - University Hospitals of Cleveland
Endocrinology
Cleveland, OH USA
2000
Residency - University of North Dakota Hospital
Internal Medicine
Fargo, ND USA
1997
Medical School - Hacettepe University School of Medicine
Ankara Turkey
1991

Certifications

  • Internal Medicine
  • Internal Medicine- Endocrinology, Diabetes & Metabolism

Specialty Interests

Cushing syndrome, acromegaly, pheochromocytoma, prolactinoma, primary aldosteronism, pituitary disorders, adrenal tumor, adrenocortical carcinoma, MEN syndromes, adrenal disorders

Awards & Honors

  • Best Doctors in America, 2007-2008 

Memberships

  • Pituitary Society
  • Endocrine Society
  • American Association of Clinical Endocrinologists
  • American Medical Association

Treatment & Services

  • Radioactive Iodine Treatment
  • Thyroid Aspiration
  • Thyroid Ultrasound

Specialty in Diseases and Conditions

  • Acromegaly
  • Addison’s Disease
  • Adrenal disorders
  • Adrenal insufficiency
  • Adrenal Insufficiency and Addison’s Disease
  • Adrenal Tumors
  • Adrenocortical Carcinoma
  • Adrenoleukodystrophy (ALD)
  • Amenorrhea
  • Androgen Deficiency (Low Testosterone)
  • Androgen Excess
  • Calcium Disorders
  • Carcinoid Syndrome
  • Conn's Syndrome
  • Cushing's Syndrome
  • Empty sella
  • Erectile Dysfunction
  • Familial Multiple Endocrine Neoplasia
  • Fasting hypoglycemia
  • Flushing Syndromes
  • Galactorrhea
  • Goiter
  • Growth hormone deficiency
  • Growth hormone excess
  • Gynecomastia
  • Hirsutism
  • Hyperaldosteronism
  • Hyperandrogenism
  • Hyperprolactinemia
  • Hypertension - High Blood Pressure
  • Hyperthyroidism
  • Hypocalcemia
  • Hypoglycemia
  • Hypogonadism
  • Hypoparathyroidism
  • Hypophysitis
  • Hypopituitarism
  • Hypothyroidism
  • Mastocytosis
  • Menopause, Male
  • Menstrual Disorders
  • Paget's Disease
  • Panhypopituitarism
  • Parathyroid Cancer
  • Parathyroid Disease and Calcium Disorders
  • Pheochromocytoma
  • Pituitary Cysts
  • Pituitary Disorders
  • Pituitary stalk lesions
  • Pituitary Tumors
  • Premenstrual Syndrome (PMS)
  • Primary Hyperaldosteronism
  • Primary Hyperparathyroidism
  • Prolactin Excess States
  • Prolactinoma
  • Thyroid and pregnancy
  • Thyroid Cancer
  • Thyroid Disease
  • Thyroid Nodule

Johns Hopkins Pituitary Day

To contact us Click HERE

MEETING NOTES : Johns Hopkins Pituitary Day


Meeting Created:September 29, 2012, 10:04 AM

Baltimore


Dr. Gary Wand

pituitary slides, growth hormone, ACTHprolactin, breast milkanterior, OxytocinADH, vassopressin, sodium, diabetes insipidusmicro/macro adenomasecretory vs nonfunctionalnormal MRIs compared to tumors

compression of pituitary

  • thyroid: energy, weight, mental function, skin, temp
  • sex hormones, drive and function
  • adrenal: light-headed, fatigue, appetite, weight, GI
Compression of surrounding structures like optic nerve

Excess hormones: prolactin, GH or cortisol

34% prolactin36% nonfunctioning

nonfunctioningsigns from compressiondiminished pituitary: sex hormones, thyroid, adrenalvisual defectsheadachesno medicationno hormone excesssurgery

prolactinomamedicationsome surgeryrarely radiation

growth hormone - acromegalysurgerymedicationradiation

cortisol, Cushing'ssymptomssurgerymedications

tsh tumor, similar symptoms to Grave'ssurgerymeds

other pit disorders

Dr. Barbara Craven, Johns Hopkins Pituitary Day

To contact us Click HERE

MEETING NOTES : Dr. Barbara Craven, Johns Hopkins Pituitary Day


Meeting Created:September 29, 2012, 10:49 AM

Baltimore


Cushing's, cyclical

dieticianstarted noticing problems early 1990s1993 people told her she had a red face, 3 little kidsmood swings, depressiongaining weight1997, Christmas, puffy face, tired, red face, no energyinternist, bloodworkEpstein-barr virus high, mono.bone biopsy - rule out cancer. bones too soft, fractured hip in 2 places falling from horse

1998, mole growing on back, removed.  then more and more, every 2 weeks mole removed, all pre-cancerous, melanoma

immune system compromised

2000, racing heart, aching in chest, cardiologist, testing for heart, beta blocker for BP

2001, getting pudgier, weight increasing, tai kwondo, still couldn't lose weight.  800 calories per day, still gaining, shrunk, hair started falling out

dermatologist, no problem.  blood test.  took cortisol and DHEA

endocrinologist (not pituitary), dex suppression test positive

MRI of pit and adrenals.

Dr. Salvatori

hard to diagnose, 9 more months of testing, UFCs, blood, symptoms but not positive tests, salivary was positive

swollen feet, chest hurting, sleeping in recliner, memory became terrible, depressed, anxiety, panic attacks, miserable, couldn't fly due to anxiety. Agreed to surgery

removed whole pituitary, only found soft spots.  didn't find pituitary tumor.  found 3mm ACTH tumor

hormones still messed up even though in remission

2006 feeling better

even now hormones can get out of balance. DI.  DDVAP

sodium got low. stopped DDVAP.  drink a lot of water now.

stick with it, don't give up.

Dr. Craven was our guest in the Guest Speakers Interview series.

Dr. Ishii, Johns Hopkins Pituitary Day

To contact us Click HERE

MEETING NOTES : Dr. Ishii, Johns Hopkins Pituitary Day


Meeting Created:September 29, 2012, 11:41 AM

Baltimore


patient participation is most important

waiting for other doctor's computer________________________

nasal issues pst-op

nose is good corridor to pituitary, endoscope

nose: smells, filters air, air flow

instruments

post-op care

problemspainsmellactivityCSF leak

tired

Dr. Redmond, Johns Hopkins Pituitary Day

To contact us Click HERE

MEETING NOTES : Dr. Redmond, Johns Hopkins Pituitary Day


Meeting Created:September 29, 2012, 12:07 PM

Baltimore


radiotherapy

indications

  • recurrence
  • persistent hormone secretion
  • inoperable
tumors repair more slowly than normal cells

IMRT Intensity modulated radiation therapy

stereotactic radiosurgerymore radiation beams, greater precisionvery small tumors 1-5 treatmentslarger 5-6 weeks

150-300 radiation beams target area

Synergy machinefor divided course of radiation

cyberknife for 1-5 treatments

short-termfatiguehair losstearful or dry eyeheadachenausea

long-termcataractsdecreased hormonesdamage to vision (rare)second tumor (rare)

tumor control 90%hormone normalization 60%

29 Eylül 2012 Cumartesi

Clinical Trials: A Crucial Key to Human Health Research

To contact us Click HERE
At the forefront of human health research today are clinical trials—studies that use human volunteers to help medical professionals observe and test new treatments for a wide array of health products and practices.
A clinical trial is a research study designed to answer specific health questions by using human volunteers to help test those answers. Carefully conducted clinical trials are the fastest and safest way to find treatments that work in people, and there are clinical trials going on all the time in virtually every area of medical research. People who volunteer to take part in clinical trials do so for several reasons, including the chance to play a more active role in their own health care, gain access to new research treatments before they are widely available and help others by contributing to medical research.
Medical Research Centre in Nairobi
This file was provided by the Tropenmuseum as part of a cooperation project. The Tropenmuseum, part of the Royal Tropical Institute, exclusively provides images that are either made by its own staff, or that are otherwise free of copyright. Attribution: Tropenmuseum of the Royal Tropical Institute (KIT).

 There are several different kinds of clinical trials, including:
  • Treatment trials to test experimental treatments, new combinations of drugs or new approaches to surgery or radiation therapy.
  • Prevention trials that look for better ways to prevent disease in people who have never had the disease, or to prevent a disease from returning. These approaches may include medicines, vitamins, vaccines, minerals or lifestyle changes.
  • Diagnostic trials to find better tests or procedures for diagnosing a particular disease or condition.
  • Screening trials that test the best way to detect certain diseases or health conditions.
  • Quality of Life trials (or Supportive Care trials) that explore ways to improve comfort and the quality of life for individuals with chronic illnesses.

How to Participate

Clinical trials are sponsored or funded by a variety of organizations or individuals, such as physicians, medical institutions, foundations, voluntary groups and pharmaceutical companies, in addition to federal agencies such as the National Institutes of Health (NIH), the U.S. Department of Defense (DOD) and the U.S. Department of Veterans Affairs (VA). Trials can take place in different locations all around the world, such as hospitals, universities, doctors' offices and community clinics.
The latest and most complete information about clinical trials today is available at the ClinicalTrials.gov web site. This is a free, confidential online resource from the National Institutes of Health (NIH), which anyone with a computer and web browser can tap into for a comprehensive listing of clinical studies—in the U.S. and abroad—sponsored by the NIH and other federal agencies, pharmaceutical companies, universities and nonprofit organizations.
Here's how it works. After you enter the ClinicalTrials.gov web site, you can search for a trial by the name of the disease, the location of the study, the type of treatment or the sponsoring institution. The results will show you what studies are under way, whether a trial is actively recruiting, the purpose of the study, where and when it will take place and whom to contact for more information.
"From the very beginning, ClinicalTrials.gov has been designed for use by patients," observes Donald A.B. Lindberg, M.D., director of the National Library of Medicine (NLM), the coordinating agency for NIH. "With patients taking an increasingly active role in their own healthcare, they now have a chance to learn more about clinical studies on everything from Alzheimer's disease to zinc supplementation. Without question, it has helped investigators with their research recruiting efforts, too."
Launched in February 2000, ClinicalTrials.gov currently contains information on more than 27,000 trials. The site has proven very popular with the public, logging approximately 8 million page views monthly and hosting over 20,000 visitors daily. The site is updated regularly, with new information added every day.
ClinicalTrials.gov has many helpful features for the consumer. If you are checking out trials on breast cancer, for example, the site also links you to the U.S. National Library of Medicine (NLM), with in-depth information on various topics, including recent news articles and an interactive tutorial. ClinicalTrials.gov also points you to the NLM Genetics Home Reference site, helping you understand possible genetic factors that can increase the incidence of the disease. It allows you to search medical journal references via NLM PubMed and links to the National Cancer Institute, the lead NIH institute on this particular topic.
"It's really one-stop shopping, allowing the user to dig deeper for information on the disease or condition after viewing the list of clinical trials," says Dr. Lindberg. "ClinicalTrials.gov is a powerful tool for the individual health care consumer, and it has untold benefits for the public health, too, as new drugs and therapies evolve from these important studies." 
If you would like to participate in a clinical trial, you can find opportunities and more information at government web sites such as:
  • ClinicalTrials.gov
  • National Cancer Institute (Cancer studies)
  • HIV/AIDS Clinical Trials (HIV and AIDS studies)
Source: Summer 2006 Issue MedlinePlus, p. 4-5. 

DISCLAIMER
HolisticLifestyle Community Blog has provided this material for information andeducation purposes only. It is not intended as a substitute for or to take theplace of medical advice. If you have a medical emergency call 911. We encourage you to discuss any decisions about yourinterest in, questions about, treatment or care, or the use of complementaryand alternative medicine (CAM), or any other therapy, and what may be best foryour overall health with a licensed physician or other qualified health careprovider. The mention of any product, service, or therapy is not an endorsementby Holistic Lifestyle Community Blog. Any mention in the Holistic LifestyleCommunity Blog of a specific brand name is not an endorsement of the product.

Addison's Disease

To contact us Click HERE
Addison’s disease, also called chronic adrenal insufficiency, hypocortisolism and hypoadrenalism, is a rare, chronic endocrine disorder in which the adrenal glands do not produce sufficient steroid hormones (glucocorticoids and often mineralocorticoids). It is characterized by a number of relatively nonspecific symptoms, such as abdominal pain and weakness, but under certain circumstances, these may progress to Addisonian crisis, a severe illness which may include very low blood pressure and coma.

The condition arises from problems with the adrenal gland itself, a state referred to as "primary adrenal insufficiency," and can be caused by damage by the body's own immune system, certain infections or various rarer causes. Addison's disease is also known as chronic primary adrenocortical insufficiency, to distinguish it from acute primary adrenocortical insufficiency, most often caused by Waterhouse-Friderichsen syndrome. Addison's disease should also be distinguished from secondary and tertiary adrenal insufficiency, which are caused by deficiency of ACTH (produced by the pituitary gland) and CRH (produced by the hypothalamus), respectively. Despite this distinction, Addisonian crises can happen in all forms of adrenal insufficiency.

Addison's disease and other form of hypoadrenalism are generally diagnosed via blood tests and medical imaging. Treatment involves replacing the absent hormones (oral hydrocortisone and fludrocortisone).[2] Lifelong, continuous treatment with steroid replacement therapy is required, with regular follow-up treatment and monitoring for other health problems.[1]

Your adrenal glands are just above your kidneys. The outside layer of these glands makes hormones that help your body respond to stress and regulate your blood pressure and water and salt balance. Addison's disease occurs if the adrenal glands don't make enough of these hormones.

Addison’s disease is named after Dr. Thomas Addison, the British physician who first described the condition in 1849. The adjective "Addisonian" is used to describe features of the condition, as well as patients suffering from Addison’s disease.[1]


Signs and Symptoms

The symptoms of Addison's disease develop insidiously, and it may take some time to be recognized. The most common symptoms are:
  • fatigue, 
  • lightheadedness upon standing or while upright, 
  • muscle weakness, 
  • fever, 
  • weight loss, 
  • difficulty in standing up, 
  • anxiety, 
  • nausea, 
  • vomiting, 
  • diarrhea, 
  • headache, 
  • sweating, 
  • changes in mood and personality, and 
  • joint and muscle pains.
Some have marked cravings for salt or salty foods due to the urinary losses of sodium.[1] Increased tanning may be noted, particularly in sun-exposed areas, as well as darkening of the palmar creases, sites of friction, recent scars, the vermilion border of the lips, and genital skin.[3] This is not encountered in secondary and tertiary hypoadrenalism.[2]

Clinical Signs:

The negative feedback loop for glucocorticoids. On examination, the following may be noticed:
  • Low blood pressure that falls further when standing (orthostatic hypotension)
  • Most people with primary Addison's have darkening (hyperpigmentation) of the skin, including areas not exposed to the sun; characteristic sites are skin creases (e.g. of the hands), nipple, and the inside of the cheek (buccal mucosa); also, old scars may darken. This occurs because melanocyte-stimulating hormone (MSH) and adrenocorticotropic hormone (ACTH) share the same precursor molecule, pro-opiomelanocortin (POMC). After production in anterior pituitary gland, POMC gets cleaved into gamma-MSH, ACTH and beta-lipotropin. The subunit ACTH undergoes further cleavage to produce alpha-MSH, the most important MSH for skin pigmentation. In secondary and tertiary forms of Addison's, skin darkening does not occur.
  • Medical conditions, such as type I diabetes, autoimmune thyroid disease (Hashimoto's thyroiditis and goiter) and vitiligo often occur together with Addison's (often in the setting of autoimmune polyendocrine syndrome). Hence, symptoms and signs of any of the former conditions may also be present in the individual with Addison's.
  • The occurrence of Addison's disease in someone who also has Hashimoto's thyroiditis is called Schmidt syndrome.

Addisonian Crisis

An "Addisonian crisis" or "adrenal crisis" is a constellation of symptoms that indicate severe adrenal insufficiency. This may be the result of either previously undiagnosed Addison's disease, a disease process suddenly affecting adrenal function (such as adrenal hemorrhage), or an intercurrent problem (e.g. infection, trauma) in someone known to have Addison's disease. It is a medical emergency and potentially life-threatening situation requiring immediate emergency treatment.

Characteristic Symptoms Are:
  • Sudden penetrating pain in the legs, lower back or abdomen
  • Severe vomiting and diarrhea, resulting in dehydration
  • Low blood pressure
  • Syncope (loss of consciousness and ability to stand)
  • Hypoglycemia (reduced level of blood glucose)
  • Confusion, psychosis, slurred speech
  • Severe lethargy
  • Hyponatremia (low sodium level in the blood)
  • Hyperkalemia (elevated potassium level in the blood)
  • Hypercalcemia (elevated calcium level in the blood)
  • Convulsions
  • Fever

Causes

Causes of adrenal insufficiency can be grouped by the way they cause the adrenals to produce insufficient cortisol. These are adrenal dysgenesis (the gland has not formed adequately during development), impaired steroidogenesis (the gland is present but is biochemically unable to produce cortisol) or adrenal destruction (disease processes leading to the gland being damaged).[1]

Adrenal Dysgenesis

All causes in this category are genetic, and generally very rare. These include mutations to the SF1 transcription factor, congenital adrenal hypoplasia (CAH) due to DAX-1 gene mutations and mutations to the ACTH receptor gene (or related genes, such as in the Triple A or Allgrove syndrome). DAX-1 mutations may cluster in a syndrome with glycerol kinase deficiency with a number of other symptoms when DAX-1 is deleted together with a number of other genes.[1]

Impaired Steroidogenesis

To form cortisol, the adrenal gland requires cholesterol, which is then converted biochemically into steroid hormones. Interruptions in the delivery of cholesterol include Smith-Lemli-Opitz syndrome and abetalipoproteinemia.

Of the synthesis problems, congenital adrenal hyperplasia is the most common (in various forms: 21-hydroxylase, 17α-hydroxylase, 11β-hydroxylase and 3β-hydroxysteroid dehydrogenase), lipoid CAH due to deficiency of StAR and mitochondrial DNA mutations.[1] Some medications interfere with steroid synthesis enzymes (e.g. ketoconazole), while others accelerate the normal breakdown of hormones by the liver (e.g. rifampicin, phenytoin).[1]

Adrenal Destruction

Autoimmune adrenalitis is the most common cause of Addison's disease in the industrialized world. Autoimmune destruction of the adrenal cortex is caused by an immune reaction against the enzyme 21-hydroxylase (a phenomenon first described in 1992).[5] This may be isolated or in the context of autoimmune polyendocrine syndrome (APS type 1 or 2), in which other hormone-producing organs, such as the thyroid and pancreas, may also be affected.[6]

Adrenal destruction is also a feature of adrenoleukodystrophy (ALD), and when the adrenal glands are involved in metastasis (seeding of cancer cells from elsewhere in the body, especially lung), hemorrhage (e.g. in Waterhouse-Friderichsen syndrome or antiphospholipid syndrome), particular infections (tuberculosis, histoplasmosis, coccidioidomycosis), deposition of abnormal protein in amyloidosis.

Corticosteroid Withdrawal

Use of high-dose steroids for more than a week begins to produce suppression of the patient's adrenal glands because the exogenous glucocorticoids suppress hypothalamic corticotropin-releasing hormone (CRH) and pituitary adrenocorticotropic hormone (ACTH). With prolonged suppression, the adrenal glands atrophy (physically shrink), and can take months to recover full function after discontinuation of the exogenous glucocorticoid. During this recovery time, the patient is vulnerable to adrenal insufficiency during times of stress, such as illness.

Diagnosis

Suggestive Features - Routine investigations may show:
  • Hypercalcemia (elevated calcium levels in the blood).
  • Hypoglycemia, low blood sugar (worse in children due to loss of glucocorticoid's glucogenic effects)
  • Hyponatremia (low blood sodium levels), due to the kidney's inability to excrete free water in the absence of sufficient cortisol, and also the effect of Corticotropin-releasing hormone to stimulate secretion of ADH. That hyponatremia occurs even in secondary adrenal insufficiency (i.e. due to pituitary disease), in which aldosterone deficiency is not a feature, underscores the fact that hyponatremia in Addison's disease is not due to lack of aldosterone.
  • Hyperkalemia (raised blood potassium levels), due to loss of production of the hormone aldosterone.
  • Eosinophilia and lymphocytosis (increased number of eosinophils or lymphocytes, two types of white blood cells)
  • Metabolic acidosis (increased blood acidity), also due to loss of the hormone aldosterone because sodium reabsorption in the distal tubule is linked with acid/hydrogen ion (H+) secretion. Low levels of aldosterone stimulation of the renal distal tubule leads to sodium wasting in the urine and H+ retention in the serum.

Testing

In suspected cases of Addison's disease, one needs to demonstrate that adrenal hormone levels are low even after appropriate stimulation (called the ACTH stimulation test) with synthetic pituitary ACTH hormone tetracosactide. Two tests are performed, the short and the long test.

The short test compares blood cortisol levels before and after 250 micrograms of tetracosactide (IM/IV) is given. If, one hour later, plasma cortisol exceeds 170 nmol/L and has risen by at least 330 nmol/L to at least 690 nmol/L, adrenal failure is excluded. If the short test is abnormal, the long test is used to differentiate between primary adrenal insufficiency and secondary adrenocortical insufficiency.

The long test uses 1 mg tetracosactide (IM). Blood is taken 1, 4, 8, and 24 hours later. Normal plasma cortisol level should reach 1000 nmol/L by 4 hours. In primary Addison's disease, the cortisol level is reduced at all stages whereas in secondary corticoadrenal insufficiency, a delayed but normal response is seen.

Other tests that may be performed to distinguish between various causes of hypoadrenalism are renin and adrenocorticotropic hormone levels, as well as medical imaging - usually in the form of ultrasound, computed tomography or magnetic resonance imaging (MRI).

Adrenoleukodystrophy, and the milder form, adrenomyeloneuropathy, cause adrenal insufficiency combined with neurological symptoms. These diseases are estimated to be the cause of adrenal insufficiency in approximately 35% of male patients with idiopathic Addison’s disease and should be considered in the differential diagnosis of any male with adrenal insufficiency. Diagnosis is made by a blood test to detect very long chain fatty acids (VLCFA).[7] 

Treatment

Treatment for Addison's disease involves replacing the missing cortisol, sometimes in the form of hydrocortisone tablets, or prednisone tablets in a dosing regimen that mimics the physiological concentrations of cortisol. Alternatively one quarter as much prednisolone may be used for equal glucocorticoid effect as hydrocortisone. Treatment must usually be continued for life. In addition, many patients require fludrocortisone as replacement for the missing aldosterone. Caution must be exercised when the person with Addison's disease becomes unwell with infection, has surgery or other trauma, or becomes pregnant. In such instances, their replacement glucocorticoids, whether in the form of hydrocortisone, prednisone, prednisolone, or other equivalent, often need to be increased. Inability to take oral medication may prompt hospital attendance to receive steroids intravenously. People with Addison's are often advised to carry information on them (e.g. in the form of a MedicAlert bracelet) for the attention of emergency medical services personnel who might need to attend to their needs. 

Crisis

Standard therapy involves intravenous injections of glucocorticoids and large volumes of intravenous saline solution with dextrose (glucose), a type of sugar. This treatment usually brings rapid improvement. When the patient can take fluids and medications by mouth, the amount of glucocorticoids is decreased until a maintenance dose is reached. If aldosterone is deficient, maintenance therapy also includes oral doses of fludrocortisone acetate.[8] 

Epidemiology

The frequency rate of Addison's disease in the human population is sometimes estimated at roughly 1 in 100,000.[9] Some research and information sites put the number closer to 40-60 cases per 1 million population. (1/25,000-1/16,600)[10] (Determining accurate numbers for Addison's is problematic at best and some incidence figures are thought to be underestimates.[11]) Addison's can afflict persons of any age, gender, or ethnicity, but it typically presents in adults between 30 and 50 years of age.[12] Research has shown no significant predispositions based on ethnicity.[10]

Prognosis

With proper medication, patients can expect to live a healthy and normal life. A person with adrenal insufficiency should always carry identification stating their condition in case of an emergency. The card should alert emergency personnel about the need to inject 100 mg of cortisol if its bearer is found severely injured or unable to answer questions. The card should also include the doctor's name and telephone number and the name and telephone number of the nearest relative to be notified. When traveling, a needle, syringe, and an injectable form of cortisol should be carried for emergencies.

A person with Addison's disease also should know how to increase medication during periods of stress or mild upper respiratory infections. Immediate medical attention is needed when severe infections, vomiting, or diarrhea occur, as these conditions can precipitate an Addisonian crisis. A patient who is vomiting may require injections of hydrocortisone, since oral hydrocortisone supplements cannot be adequately metabolised.

History

Addison’s disease is named after Dr. Thomas Addison, the British physician who first described the condition in On the Constitutional and Local Effects of Disease of the Suprarenal Capsules (1849).[13] All of Addison's six original patients had tuberculosis of the adrenal glands.[14] While Addison's six patients in 1855 all had adrenal tuberculosis, the term "Addison's disease" does not imply an underlying disease process.

Famous Addisonians
  • United States President John F. Kennedy (1961-63), probably the single most famous case of Addison's Disease. United States President John F. Kennedy was one of the best-known Addison's disease sufferers. He was possibly one of the first Addisonians to survive major surgery.[15] There was substantial secrecy surrounding his health during his years as president.[16]
  • Eunice Kennedy Shriver, one of John F. Kennedy's sisters, was believed to have Addison's disease, as well.[17]
  • Popular singer Helen Reddy[18]
  • Scientist Eugene Merle Shoemaker, codiscoverer of the Comet Shoemaker-Levy 9.[19]
  • French Carmelite nun and religious writer Blessed Elizabeth of the Trinity[20]
  • American artist Ferdinand Louis Schlemmer died from Addison's disease.
  • Some have suggested that Jane Austen was an avant la lettre case, but others have disputed this.[21]
  • According to Dr. Carl Abbott, a Canadian medical researcher, Charles Dickens may also have been affected.[22]
  • Australia's youngest rugby league football international, Geoff Starling[23]
  • Basque nationalist and founder of the Basque Nationalist Party, Sabino Arana died in Sukarrieta at the age of 38 after falling ill with Addison's disease during time spent in prison.
  • One of Canada's top gymnasts, Nathan Gafuik who was diagnosed with Addison's disease when he was 15.

In Other Animals

The condition has been diagnosed in all breeds of dogs. In general, it is underdiagnosed, and one must clinically suspect it as an underlying disorder for many presenting complaints. Females are overrepresented, and the disease often appears in middle age (4–7 years), although any age or gender may be affected. Genetic continuity between dogs and humans helps to explain the occurrence of Addison's disease in both species.[26]

Hypoadrenocorticism is treated with fludrocortisone or a monthly injection called Percorten V (desoxycorticosterone pivlate (DOCP)) and prednisone. Routine blood work is necessary in the initial stages until a maintenance dose is established.

Most of the medications used in the therapy of hypoadrenocorticism cause excessive thirst and urination, making it important to provide enough drinking water.

If the owner knows about an upcoming stressful situation (shows, traveling, etc.), patients generally need an increased dose of prednisone to help deal with the added stress. Avoidance of stress is important for dogs with hypoadrenocorticism.

External Links

Adrenal Insufficiency and Addison's Disease - National Institute of Diabetes and Digestive and Kidney Diseases.
Addison's Disease - American Academy of Family Physicians.
Addison's Disease - Mayo Foundation for Medical Education and Research.

Diagnosis/Symptoms
ACTH (Adrenocorticotropic Hormone) Test - American Association for Clinical Chemistry.
Aldosterone and Renin Test - American Association for Clinical Chemistry.
Cortisol Test - American Association for Clinical Chemistry.

Disease Management
Managing Adrenal Insufficiency - National Institutes of Health, Clinical Center.

Clinical Trials
ClinicalTrials.gov: Adrenal Insufficiency, Addison's Disease - National Institutes of Health.

Directories
Directory of Endocrine and Metabolic Diseases Organizations - National Institute of Diabetes and Digestive and Kidney Diseases.

Organizations
National Institute of Diabetes and Digestive and Kidney Diseases.
National Adrenal Diseases Foundation (USA).
Addison's Disease Self-Help Group (UK).
The National Endocrine and Metabolic Diseases Information Service.

References
1. Ten S, New M, Maclaren N (2001). "Clinical review 130: Addison's disease 2001". J. Clin. Endocrinol. Metab. 86 (7): 2909–22. doi:10.1210/jc.86.7.2909. PMID 11443143. http://jcem.endojournals.org/cgi/content/full/86/7/2909.
2. de Herder WW, van der Lely AJ (May 2003). "Addisonian crisis and relative adrenal failure". Rev Endocr Metab Disord 4 (2): 143–7. doi:10.1023/A:1022938019091. PMID 12766542.
3. Nieman LK, Chanco Turner ML (2006). "Addison's disease". Clin. Dermatol. 24 (4): 276–80. doi:10.1016/j.clindermatol.2006.04.006. PMID 16828409.
4. Addison's Disease National Endocrine and Metabolic Diseases Information Service. Retrieved on 26 October 2007.
5. Winqvist O, Karlsson FA, Kämpe O (June 1992). "21-Hydroxylase, a major autoantigen in idiopathic Addison's disease". Lancet 339 (8809): 1559–62. doi:10.1016/0140-6736(92)91829-W. PMID 1351548.
6. Husebye ES, Perheentupa J, Rautemaa R, Kämpe O (May 2009). "Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I". J. Intern. Med. 265 (5): 514–29. doi:10.1111/j.1365-2796.2009.02090.x. PMID 19382991.
7. Lauretti, S; Casucci, G; Santeisanio, F; Angeletti, G; Aubourg, P; Brunetti, P (1996). "X-linked adrenoleukodystrophy is a frequent cause of idiopathic Addison's disease in young adult male patient". J Clin Endocrinol Metab 81 (2): 470–474. doi:10.1210/jc.81.2.470. PMID 8636252
8. National Endocrine and Metabolic Diseases Information Service. Retrieved on 26 November 2010.
9. "Addison Disease Health information regarding this hormonal (endocrine) disorder on MedicineNet.com". Archived from the original on 24 June 2007. http://www.medicinenet.com/addison_disease/article.htm. Retrieved 2007-07-25.
10. "eMedicine - Addison Disease : Article by Sylvester Odeke". Archived from the original on 7 July 2007. http://www.emedicine.com/med/topic42.htm. Retrieved 2007-07-25.
11. "medhelp". Archived from the original on 2007-07-06. http://web.archive.org/web/20070706231235/http://www.medhelp.org/www/nadf3.htm. Retrieved 2007-07-25.
12. Volpé, Robert (1990). Autoimmune Diseases of the Endocrine System. CRC Press. pp. 299. ISBN 0-8493-6849-9.
13. Thomas Addison (1855). On The Constitutional And Local Effects Of Disease Of The Supra-Renal Capsules. London: Samuel Highley. http://www.wehner.org/addison/x1.htm.
14. Patnaik MM, Deshpande AK (May 2008). "Diagnosis–Addison's Disease Secondary to Tuberculosis of the Adrenal Glands". Clin Med Res 6 (1): 29. doi:10.3121/cmr.2007.754a. PMC 2442022. PMID 18591375. http://www.clinmedres.org/cgi/content/full/6/1/29.
15. Nicholas JA, Burstein CL, Umberger CJ, Wilson PD (November 1955). "Management of adrenocortical insufficiency during surgery". AMA Arch Surg 71 (5): 737–42. PMID 13268224.
16. Owen, David (May 2003). "Diseased, demented, depressed: serious illness in Heads of State". QJM 96 (5): 325–36. doi:10.1093/qjmed/hcg061. PMID 12702781. http://qjmed.oxfordjournals.org/cgi/content/full/96/5/325.
17. Dallek, Robert (2003). An Unfinished Life: John F. Kennedy, 1917-1963. London: Penguin Books. pp. 105, 731. ISBN 978-0-14-101535-4.
18. "The Australian Addison's Disease Association". http://www.addisons.org.au/core.htm?page=/awareness/awarenessweek.htm. Retrieved 2007-07-25.
19. Marsden, Brian (1997-07-18). "Eugene Shoemaker (1928-1997)". Comet Shoemaker-Levy Collision with Jupiter. Jet Propulsion Laboratory. Archived from the original on 11 July 2007. http://www2.jpl.nasa.gov/sl9/news81.html. Retrieved 2007-07-25.
20. Jones, Terry. "Patron Saints Index: Blessed Elizabeth of the Trinity". Archived from the original on 11 May 2008. http://saints.sqpn.com/sainte46.htm. Retrieved 2008-05-04.
21. Upfal, Annette (2005). "Jane Austen's lifelong health problems and final illness: New evidence points to a fatal Hodgkin's disease and excludes the widely accepted Addison's". Medical Humanities (BMJ Publishing Group) 31 (1): 3–11. doi:10.1136/jmh.2004.000193. http://mh.bmj.com/cgi/content/full/31/1/3.
22. L. Williams et al. (1991). "The Nineteenth Century: Victorian Period". The Year's Work in English Studies (Oxford University Press) 72 (1): pp. 314–360. doi:10.1093/ywes/72.1.314. http://ywes.oxfordjournals.org/cgi/content/long/72/1/314.
23. Chersterton, Ray (11 May 2007). "The cruelty of sport". The Daily Telegraph. http://www.dailytelegraph.com.au/sport/nrl/the-cruelty-of-sport/story-e6frexnr-1111113510010. Retrieved 2 January 2012.
24. Wright, Lawrence (2006). The Looming Tower. New York City: Knopf. p. 139. ISBN 978-0-375-41486-2.
25. "Addison’s disease makes Gafuik a fighter". The Globe and Mail. 20 July 2012. http://www.theglobeandmail.com/sports/olympics/addisons-disease-makes-gafuik-a-fighter/article4429100/?cmpid=rss1. Retrieved 20 July 2012.
26. "Dog Days Of Science". Archived from the original on 21 September 2008. http://grants.nih.gov/grants/policy/air/dog_days.htm. Retrieved 2008-09-01. 
DISCLAIMERThesestatements have not been approved by the U.S. Food and Drug Administration(FDA).  This information is not intendedto diagnose, treat, cure or prevent any disease. Information conveyed herein isbased on pharmacological and other records - both ancient and modern. No claimswhatsoever can be made as to the specific benefits accruing from the use of anyherb, essential oil, or nutritional supplement.
HolisticLifestyle Community Blog has provided this material for information andeducation purposes only. It is not intended as a substitute for or to take theplace of medical advice. We encourage you to discuss any decisions about yourinterest in, questions about, treatment or care, or the use of complementaryand alternative medicine (CAM), or any other therapy, and what may be best foryour overall health with a licensed physician or other qualified health careprovider. The mention of any product, service, or therapy is not an endorsementby Holistic Lifestyle Community Blog. Any mention in the Holistic LifestyleCommunity Blog of a specific brand name is not an endorsement of the product.

Color Psychology

To contact us Click HERE
Color psychology is the study of color as a factor in human behavior. This includes very diverse studies, ranging from quantifying individual color preference[1] to investigating the relationship between shirt color and match outcome in English football.[2] In ways color psychology is a rather young direction in research, in that it is has not been strongly propagated in clinical settings.
Prismatic Color Wheel
Biochemistry
When a yellow wall is hit by white light, be it sunlight or artificial, the wavelengths of the color yellow reflect off the wall into our eyes, stimulating our brain.[3] Different colors emit different lengths of wavelengths of light - some shorter, some longer - when they are hit by white light; this light is energy which can stimulate different parts of the brain, particularly through the retina and skin. The general concept is not dissimilar to how sunlight produces growth in plants; different light wavelengths are essentially exercising and forcing growth and activation of different parts of the brain. A long wavelength of a bright yellow room will stimulate emotional, irrational parts of the brain, whereas a deep blue with a far shorter wavelength has a calming effect and tends to stimulate cold rationale, logic, and mathematical parts of the brain. 


Influence of Color on Perception
Perceptions not obviously related to color, such as the palatability of food, may in fact be partially determined by color. Not only the color of the food itself but also that of everything in the eater's field of vision can affect this.

Placebo Effect
The color of placebo pills is reported to be a factor in their effectiveness, with "hot-colored" pills working better as stimulants and "cool-colored" pills working better as depressants. This relationship is believed to be a consequence of the patient's expectations and not a direct effect of the color itself.[3] Consequently, these effects appear to be culture-dependent.[4] 

Blue Public Lighting
In 2000, Glasgow installed blue street lighting in certain neighborhoods and subsequently reported the anecdotal finding of reduced crime in these areas. This report was picked up by several news outlets.[5][6] A railroad company in Japan installed blue lighting on its stations in October 2009 in an effort to reduce the number of suicide attempts,[7] although the effect of this technique has been questioned.[8] 

Color Preference and Associations between Color and Mood
Color has long been used to create feelings of coziness or spaciousness. However, how people are affected by different color stimuli varies from person to person.

Blue is the top choice for 35% of Americans, followed by green (16%), purple (10%) and red (9%).[9] A preference for blue and green may be due to a preference for certain habitats that were beneficial in the ancestral environment as explained in the evolutionary aesthetics article.[10]

There is evidence that color preference may depend on ambient temperature. People who are cold prefer warm colors like red and yellow while people who are hot prefer cool colors like blue and green.[1]  Some research has concluded that women and men respectively prefer "warm" and "cool" colors.[1]

A few studies have shown that cultural background has a strong influence on color preference. These studies have shown that people from the same region regardless of race will have the same color preferences. Also, one region may have different preferences than another region (i.e., a different country or a different area of the same country), regardless of race.[1]

Children's preferences for colors they find to be pleasant and comforting can be changed and can vary, while adult color preference is usually non-malleable.[1]

Some studies find that color can affect mood. However, these studies do not agree on precisely which moods are brought out by which colors.[1]

Despite cross-cultural differences regarding what different colors meant there were cross-cultural similarities regarding what emotional states people associated with different colors in one study. For example, the color red was perceived as strong and active.[11] 

Light, Color, and Surroundings
Light and color can influence how people perceive the area around them. Different light sources affect how the colors of walls and other objects are seen. Specific hues of colors seen under natural sunlight may vary when seen under the light from an incandescent (tungsten) light-bulb: lighter colors may appear to be more orange or "brownish" and darker colors may appear even darker.[12] Light and the color of an object can affect how one perceives its positioning. If light or shadow, or the color of the object, masks an object's true contour (outline of a figure) it can appear to be shaped differently than it really is.[12] Objects under a uniform light-source will promote better impression of three-dimensional shape.[12]

The color of an object may affect whether or not it seems to be in motion. In particular, the trajectories of objects under a light source whose intensity varies with space are more difficult to determine than identical objects under a uniform light source. This could possibly be interpreted as interference between motion and color perception, both of which are more difficult under variable lighting.[12] 

Color in Jungian Psychology
Carl Jung is most prominently associated with the pioneering stages of color psychology. Jung was most interested in colors’ properties and meanings, as well as in art’s potential as a tool for psychotherapy. His studies in and writings on color symbolism cover a broad range of topics, from mandalas to the works of Picasso to the near-universal sovereignty of the color gold, the lattermost of which, according to Charles A. Riley II, “expresses … the apex of spirituality, and intuition”.[13] In pursuing his studies of color usage and effects across cultures and time periods, as well as in examining his patients’ self-created mandalas, Jung attempted to unlock and develop a language, or code, the ciphers of which would be colors. He looked to alchemy to further his understanding of the secret language of color, finding the key to his research in alchemical transmutation. His work has historically informed the modern field of color psychology. 

General Model of Color Psychology
The general model of color psychology relies on six basic principles. First is that color can carry specific meaning. Second, color meaning is either based in learned meaning or biologically innate meaning. Third, the perception of a color causes evaluation automatically by the person perceiving. Fourth, the evaluation process forces color motivated behavior. Fifth, color usually exerts its influence automatically. Last, color meaning and effect has to do with context as well.[14] 

Uses in Marketing
Given that people make up their minds about whether or not to buy something within ninety seconds of first encounter, color psychology has become important to marketing. The color red is believed to increase appetite, and is thus commonly used in fast food restaurants. On the other hand, the color red is believed to relax people, and is thus used by higher class restaurants to persuade customers to stay longer.

Color may also affect subjective time. Red and blue are respectively believed to make time appear to pass more quickly and more slowly. Casinos, for example, use red lighting in an attempt to keep customers inside for a longer period of time.[15] Color may also affect brand perceptions, such as brand personality [16]. 

Color and Sports Performance
In particular the color red has been found to influence sports performance. During the 2004 Summer Olympics the competitors in boxing, taekwondo, freestyle wrestling, and Greco-Roman wrestling were randomly given blue or red uniforms. A later study found that those wearing red won 55% of all the bouts which was a statistically significant increase over the expected 50%. The colors affected bouts where the competitors were closely matched in ability, where those wearing red won 60% of the bouts, but not bouts between more unevenly matched competitors.

In England, since WWII, teams wearing red uniforms have averaged higher league positions and have had more league winners than teams using other colors. In cities with more than one team, the teams wearing red outperformed the teams wearing other colors. A study of the UEFA Euro 2004 found similar results. Another study found that those taking penalty kicks performed worst when the goalkeeper had a red uniform. More anecdotal is the historical dominance of the domestic honors by red-wearing teams such AFC Ajax, FC Bayern Munich, Liverpool F.C., and Manchester United F.C.. Videos of taekwondo bouts were manipulated in one study so that the red and blue colors of the protective gears were reversed. Both the original and the manipulated videos were shown to referees. The competitors wearing red were given higher scores despite the videos otherwise being identical. A study on experienced players of first-person shooters found that those assigned to wear red instead of blue won 55% of the matches.[11]

There are several different explanations for this effect. Red is used in stop signs and traffic lights which may associate the color with halting. Red is also perceived as a strong and active color which may influence both the person wearing it and others. An evolutionary psychology explanation is that red may signal health as opposed to anemic paleness as well indicate anger due to flushing instead of paleness due to fear. It has been argued that detecting flushing may have influenced the development of primate trichromatic vision. Primate studies have found that some species evaluate rivals and possible also mates depending on red color characteristics. Facial redness is associated with testosterone levels in humans and male skin tend to be redder than female skin.[11] 

Color Symbolism
Color symbolism in art and anthropology refers to the use of color as a symbol in various cultures. There is great diversity in the use of colors and their associations between cultures[1] and even within the same culture in different time periods.[2] In fact, the same color may have very different associations within the same culture at any time. For example, the colors red [and green] are often used in North America and Europe for traffic signals[3] or to alert a person to danger.[4] At the same time, red is also frequently used in association with romance, e.g. with Valentine's Day.[5]

Symbolic representations of religious concepts or articles may include a specific color with which the concept or object is associated.[6] There is evidence to suggest that colors have been used for this purpose as early as 90,000 BC.[7] 

Criticism
Inherent difficulties in properly controlling trials of color's effect on human beings mean that a subject's expectations and cultural bias cannot be ruled out. Moreover, much evidence is anecdotal (e.g. the blue street lighting case) or based on data that includes confounders (e.g. the shirt-color correlation). Chromotherapy, a form of alternative medicine, is based on the hypothesis that distinct colors have health effects[13] unrelated to the aforementioned placebo effect.
References 1. Whitfield, T. W. A., & Wiltshire, T. J. (1990). Color psychology: A critical review. Genetic, Social & General Psychology Monographs, 116(4), 387, http://web.ebscohost.com/ehost/detail?vid=1&hid=113&sid=e386d5f5-ca68-469f-bfd4-19238321e445%40sessionmgr111&bdata=JnNpdGU9ZWhvc3QtbGl2ZSZzY29wZT1zaXRl#db=aph&AN=9604163308#db=aph&AN=9604163308 2. Attrill, M.; Gresty, K.; Hill, R.; Barton, R. (2008). "Red shirt colour is associated with long-term team success in English football". Journal of sports sciences 26 (6): 577–582. doi:10.1080/02640410701736244. PMID 18344128. 3. De Craen, A. J.; Roos, P. J.; Leonard De Vries, A.; Kleijnen, J. (1996). "Effect of colour of drugs: Systematic review of perceived effect of drugs and of their effectiveness". BMJ (Clinical research ed.) 313 (7072): 1624–1626. doi:10.1136/bmj.313.7072.1624. PMC 2359128. PMID 8991013. 4. Dolinska, B. (1999). "Empirical investigation into placebo effectiveness" (w). Irish Journal of Psychological Medicine 16 (2): 57–58. Retrieved 2009-04-29. 5. "Blue streetlights believed to prevent suicides, street crime". The Seattle Times. 2008-12-11. 6. Shimbun, Yomiuri (December 10, 2008). "Blue streetlights may prevent crime, suicide". 7. Can Blue-Colored Light Prevent Suicide? 8. Will Blue Lights Reduce Suicides in Japan? 9. Emotional Reactions to Color by Kathy Lamancusa 10. Dutton, Denis. 2003. 'Aesthetics and Evolutionary Psychology' in "The Oxford Handbook for Aesthetics". Oxford University Press. 11. Diana Widermann, Robert A. Barton, and Russel A. Hill. Evolutionary perspectives on sport and competition. In Roberts, S. C. (2011). Applied Evolutionary Psychology. Oxford University Press. doi:10.1093/acprof:oso/9780199586073.001.0001. ISBN 9780199586073. 12. Shevell, S. K.; Kingdom, F. A. A. (2008). "Color in Complex Scenes". Annual Review of Psychology 59: 143–166. doi:10.1146/annurev.psych.59.103006.093619. PMID 18154500. 13. Riley, Charles A. II. “Color Codes: Modern Theories of Color in Philosophy, Painting and Architecture, Literature, Music, and Psychology”. Hanover: University Press of New England, 1995, p. 307. 14. Whitfield, T. W., & Whiltshire, T. J. (1990). Color psychology: A critical review. Genetic, Social, General Psychology Monographs, 116(4). 15. Singh, S. (2006). "Impact of color on marketing". Management Decision 44 (6): 783. doi:10.1108/00251740610673332. 16. Labrecque, L. I.; Milne, G. R. (2011). "Exciting red and competent blue: The importance of color in marketing". Journal of the Academy of Marketing Science. doi:10.1007/s11747-010-0245-y. 17. Azeemi, Y; Raza SM (2005). "A Critical Analysis of Chromotherapy and Its Scientific Evolution". Evidence-Based Complementary Alternative Medicine 2 (4): 481–488. doi:10.1093/ecam/neh137. PMC 1297510. PMID 16322805.

    DISCLAIMER
    Thesestatements have not been approved by the U.S. Food and Drug Administration(FDA).  This information is not intendedto diagnose, treat, cure or prevent any disease. Information conveyed herein isbased on pharmacological and other records - both ancient and modern. No claimswhatsoever can be made as to the specific benefits accruing from the use of anyherb, essential oil, or nutritional supplement.

    HolisticLifestyle Community Blog has provided this material for information andeducation purposes only. It is not intended as a substitute for or to take theplace of medical advice. If you have a medical emergency call 911. We encourage you to discuss any decisions about yourinterest in, questions about, treatment or care, or the use of complementaryand alternative medicine (CAM), or any other therapy, and what may be best foryour overall health with a licensed physician or other qualified health careprovider. The mention of any product, service, or therapy is not an endorsementby Holistic Lifestyle Community Blog. Any mention in the Holistic LifestyleCommunity Blog of a specific brand name is not an endorsement of the product.